best practices for vaccines after sct and cellular therapy & the role of pharmacists in this process
Published 1 year ago • 82 plays • Length 4:49Download video MP4
Download video MP3
Similar videos
-
3:37
implementing pharmacogenomics-driven supportive care for stem cell transplant recipients
-
1:29
vaccination after stem cell transplant – why and when?
-
0:46
is there potential for the use of combination therapies in sickle cell disease?
-
1:48
do all patients require maintenance therapy following allosct?
-
1:08
managing chronic pain in patients with sickle cell disease
-
1:17
adult stem cell transplantation for the treatment of scd
-
1:45
comparing salvage transplantion to car t-cell therapy for treating relapsed multiple myeloma
-
3:24
replacing autosct with immunotherapies: pros and cons
-
2:13
personalizing the timing of sct in patients with myelofibrosis
-
2:00
the effectiveness of ambulatory care for patients undergoing stem cell transplantation
-
3:46
patient selection for sct & recent updates in strategies to reduce gvhd & relapse following sct
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
3:09
treatment strategies for chl patients after auto-hsct
-
2:09
improving transplantation outcomes in patients with active aml: current approaches & future outlooks
-
4:06
treating covid-19 with modified t-cells for immunocompromised patients
-
1:26
improving survivorship care in transplant recipients
-
59:29
transfusion in haemopoietic stem cell transplant patients webinar 2021
-
8:05
patient selection for autologous stem cell transplantation